ERb and breast cancer: A potential predictive and prognostic biomarker and novel therapeutic drug target

被引：0
作者：
Hawse, J. R.
Subramaniam, M.
Reese, J. M.
Wu, X.
Negron, V.
Gingery, A.
Pitel, K. S.
Shah, S. S.
Cunliffe, H. E.
McCullough, A. E.
Pockaj, B. A.
Couch, F. J.
Reynolds, C.
Lingle, W. L.
Suman, V. J.
Spelsberg, T. C.
Goetz, M. P.
Ingle, J. N.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Translat Genom Res Inst, Phoenix, AZ USA
[3] Mayo Clin, Scottsdale, AZ USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P6-04-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
    Kar, Souvik
    Perrelli, Andrea
    Bali, Kiran Kumar
    Mastrocola, Raffaella
    Kar, Arpita
    Khan, Bushra
    Gand, Luis
    Nayak, Arnab
    Hartmann, Christian
    Kunz, Wolfram S.
    Samii, Amir
    Bertalanffy, Helmut
    Retta, Saverio Francesco
    GENES & DISEASES, 2024, 11 (01) : 67 - 71
  • [32] miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer
    Bai, Hua
    Wu, Suhui
    ONCOTARGETS AND THERAPY, 2019, 12 : 11069 - 11082
  • [33] MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer
    Jiang, Lin-hong
    Zhang, He-da
    Tang, Jin-hai
    JOURNAL OF ONCOLOGY, 2018, 2018
  • [34] KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer
    Wang, Xingwei
    Sun, Ru
    Hong, Xia
    Chen, Chen
    Ding, Yan
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [35] DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer
    Mahadevappa, Ravikiran
    Neves, Henrique
    Yuen, Shun Ming
    Jameel, Muhammad
    Bai, Yuchen
    Yuen, Hiu-Fung
    Zhang, Shu-Dong
    Zhu, Youzhi
    Lin, Yao
    Kwok, Hang Fai
    CANCERS, 2018, 10 (09)
  • [36] Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
    John L McElwee
    Sunish Mohanan
    Obi L Griffith
    Heike C Breuer
    Lynne J Anguish
    Brian D Cherrington
    Ashley M Palmer
    Louise R Howe
    Venkataraman Subramanian
    Corey P Causey
    Paul R Thompson
    Joe W Gray
    Scott A Coonrod
    BMC Cancer, 12
  • [37] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Michael J. Duffy
    Naoise C. Synnott
    John Crown
    Breast Cancer Research and Treatment, 2018, 170 : 213 - 219
  • [38] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Duffy, Michael J.
    Synnott, Naoise C.
    Crown, John
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 213 - 219
  • [39] Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
    McElwee, John L.
    Mohanan, Sunish
    Griffith, Obi L.
    Breuer, Heike C.
    Anguish, Lynne J.
    Cherrington, Brian D.
    Palmer, Ashley M.
    Howe, Louise R.
    Subramanian, Venkataraman
    Causey, Corey P.
    Thompson, Paul R.
    Gray, Joe W.
    Coonrod, Scott A.
    BMC CANCER, 2012, 12
  • [40] Limitrin (DICAM): a new prognostic biomarker and therapeutic target for breast cancer brain metastasis
    Denoyer, D.
    Kim, S. H.
    Redvers, R. P.
    Nagpal, A.
    Fuentes, M.
    Anderson, R.
    Pouliot, N.
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (02) : 157 - 157
12345